Prosecution Insights
Last updated: August 16, 2026
Application No. 18/690,388

A POLYMER MATERIAL FOR USE IN A 3D PRINTING PROCESS

Non-Final OA §103
Filed
Mar 08, 2024
Priority
Oct 14, 2021 — EU 21202768.4 +1 more
Examiner
CHIDIAC, NICHOLAS J
Art Unit
1744
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Sika Technology AG
OA Round
3 (Non-Final)
54%
Grant Probability
Moderate
3-4
OA Rounds
7m
Est. Remaining
87%
With Interview

Examiner Intelligence

Grants 54% of resolved cases
54%
Career Allowance Rate
113 granted / 211 resolved
-11.4% vs TC avg
Strong +33% interview lift
Without
With
+33.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
34 currently pending
Career history
252
Total Applications
across all art units

Statute-Specific Performance

§101
3.6%
-36.4% vs TC avg
§103
47.4%
+7.4% vs TC avg
§102
22.8%
-17.2% vs TC avg
§112
22.7%
-17.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 211 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on July 8, 2026 has been entered. Response to Amendment Claims 1-6 and 8-15 are pending. Claim 1 has been amended. Claim 7 has been canceled. The rejections are revised in view of the amendment. Claims 13-15 have been withdrawn. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 1-6 and 8-12 is/are rejected under 35 U.S.C. 103 as being unpatentable over Gorin (US 2021/0299948) in view of Peterson (US 2021/0206051), with claim 4 as evidenced by Chang (US 2019/0017222) and claim 9 as evidenced by Wolters (US 20070213439). Regarding claim 1, Gorin discloses a method of manufacturing a 3D article (FFF AM, abstract), comprising manufacturing the 3D article from a polymer material by an additive manufacturing process (FFF AM, abstract), the polymer material comprising: a) at least one polyethylene (HDPE and LDPE, abstract, [0011] [0033]) having a density at 23 °C determined according to EN ISO 1183-1:2019 standard of at least 0.930 kg/m3 (Table 2, [0035]) and a crystallinity determined according to EN ISO 11357-3:2018 standard of at least 50 wt.-% (crystalline, [0024], with all other limitations met, this property is considered inherent), b) at least one solid filler (silicates, [0030]), and c) optionally at least one nucleating agent ([0030]), and wherein the at least one polyethylene comprises at least 50 wt.-% of a total weight of the polymer material (1.5/1 to 20/1 HDPE to a second thermoplastic polymer (one of the options for which is LDPE, [0006]). Gorin teaches a method substantially as claimed. Gorin does not disclose wherein the at least one solid filler is a fibrous filler having a volume-based mean aspect ratio of length/diameter of 3 – 60, and the at least one solid filler is needle-shaped Wollastonite. However, in the same field of endeavor of polymer compositions for FFF (abstract), Peterson teaches wherein the at least one solid filler is a fibrous filler having a volume-based mean aspect ratio of length/diameter of 3 – 60 (glass fibers, 4-40, [0085-86] [0125]), and the at least one solid filler is needle-shaped Wollastonite (Wollastonite with a relatively high aspect ratio, [0084] [0086]). It would have been prima facie obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have modified the method of Gorin such that the filler of Gorin has a volume-based mean aspect ratio within the recited range because Gorin is silent as to this attribute of the filler and [0085-86] of Peterson teaches aspect ratios within the recited range for fillers in the same technical context of fused filament fabrication. Further, [0084] of Peterson that such fillers can be Wollastonite and [0086] teaches a relatively high aspect ratio, thereby suggesting that, among the aspect ratios of Wollastonite for the filler, the aspect ratio should be relatively high and therefore needle-shaped. Regarding claim 2, Gorin as modified teaches wherein the additive manufacturing process is a fused filament fabrication process (abstract). Regarding claim 3, Gorin as modified teaches wherein the at least one polyethylene has a melt flow index (190 °C/2.16 kg) determined according to ISO 1133-1:2011 standard of at least 1 g/10 min (overlapping range, Gorin [0024]; true for all listed embodiments in [0033] of Gorin). Regarding claim 4, Gorin as modified teaches wherein the at least one polyethylene has a flexural modulus at 23 °C determined according to ISO 178:2019 standard of at least 450 MPa (DMDA 8940 has a Flexural Modulus of 148000psi (1020MPa), Gorin [0024]; as evidenced by [0050], Table 3 of Chang). Regarding claim 5, Gorin as modified teaches wherein the at least one polyethylene comprises at least 75 wt.-% of the total weight of the polymer material (20/1 ratio of HDPE/STP [0030]). Regarding claim 6, Gorin in view of Peterson teaches wherein the at least one solid filler has a volume-based mean particle diameter D50 of not more than 50μm (as modified, overlapping range, Peterson [0086], see MPEP 2144.05(I)). Regarding claim 8, Gorin in view of Peterson teaches wherein the at least one solid filler comprises 5 - 35 wt.-% of the total weight of the polymer material (overlapping range, majority of the blend is HDPE, Gorin [0030]). Regarding claim 9, Gorin as modified teaches wherein the at least one nucleating agent is selected from the group consisting of nanoscale calcium carbonate, titanium dioxide, barium sulfate, silicon dioxide, expanded graphite, montmorillonite clay, talc, multiwall carbon nanotubes, vermiculite nanocomposite minerals, 1,2-cyclohexanedicarboxylic acid, calcium salts, anthracene, potassium hydrogen phthalate, benzoic acid and derivatives thereof, and sodium benzoate and derivatives thereof (HPN-20E from Milliken is a calcium salt, Gorin [0030]; see [0007] of Wolters). Regarding claim 10, Gorin as modified teaches wherein the at least one nucleating agent comprises 0.1 - 10 wt.-% of the total weight of the polymer material (overlapping range, majority of the blend is HDPE, Gorin [0030]). Regarding claim 11, Gorin as modified teaches wherein the additive manufacturing process includes: i) providing a digital model of the 3D article (CAD or other methodology with predetermined planning for production, [0019]), ii) based on the digital model, printing the polymer material using a 3D printer to form the 3D article ([0019]). Regarding claim 12, Gorin as modified teaches wherein the 3D printer is a fused filament fabrication printer (abstract, [0017]). Response to Arguments Applicant's arguments filed July 8, 2026 have been fully considered but they are not persuasive. Applicant argues that Peterson fails to teach that a filler in needle-shaped Wollastonite and argues that use of needle-shaped Wollastonite yields unexpected results. This argument is not persuasive because, as Applicant acknowledges, [0084] of Peterson teaches Wollastonite. Applicant’s alleged unexpected results does not compare a lower aspect ratio of Wollastonite with needle-shaped Wollastonite, let alone a comparison to the other fillers taught in Peterson. Accordingly, the data does not present the alleged unexpected result relative to the alternative taught in the art. Further, [0086] of Peterson teaches that the filler material should have a relatively high aspect ratio. This teaching suggests that the use of higher aspect ratio Wollastonite would have been expected to have better results than a filler with a lower aspect ratio. Applicant’s remaining arguments addressing other arguments are based on the alleged deficiency of Peterson and are similarly unpersuasive. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. [0043] of Kim (US 2012/0329938; US 2014/0309356; US 8,815,993; US 9,150,704) teaches needle form wollastonite for use as a filler in a plastic resin composition to form extruded pellets. Any inquiry concerning this communication or earlier communications from the examiner should be directed to NICHOLAS J CHIDIAC whose telephone number is (571)272-6131. The examiner can normally be reached 8:30 AM - 6:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sam Xiao Zhao can be reached at 571-270-5343. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NICHOLAS J CHIDIAC/Examiner, Art Unit 1744 /XIAO S ZHAO/Supervisory Patent Examiner, Art Unit 1744
Read full office action

Prosecution Timeline

Mar 08, 2024
Application Filed
Oct 01, 2025
Non-Final Rejection mailed — §103
Jan 14, 2026
Response Filed
Apr 09, 2026
Final Rejection mailed — §103
Jul 08, 2026
Request for Continued Examination
Jul 11, 2026
Response after Non-Final Action
Jul 17, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12686185
FIBER PLACEMENT MACHINE WITH COMPOSITE TAPE FILM REMOVAL
5y 10m to grant Granted Jul 21, 2026
Patent 12686175
METHOD OF PRINTING A MULTI-MATERIAL 3D PART AND PURGE TOWER
2y 10m to grant Granted Jul 21, 2026
Patent 12686155
POLYURETHANE LOGO LABEL MANUFACTURING METHOD AND POLYURETHANE LOGO LABEL ATTACHMENT METHOD
1y 12m to grant Granted Jul 21, 2026
Patent 12677888
PADDING MATERIALS FOR PROTECTIVE PRODUCTS AND METHODS OF PRODUCING THE SAME
2y 4m to grant Granted Jul 14, 2026
Patent 12629887
RECOAT ASSEMBLIES INCLUDING POWDER CONTAINMENT MECHANISMS AND ADDITIVE MANUFACTURING SYSTEMS INCLUDING SAME
2y 8m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
54%
Grant Probability
87%
With Interview (+33.4%)
3y 0m (~7m remaining)
Median Time to Grant
High
PTA Risk
Based on 211 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month